Description

FOXO4-DRI 10mg

FOXO4-DRI 10mg is a synthetic D-retro-inverso (DRI) peptide developed for advanced research involving cellular senescence, aging biology, and senolytic mechanisms. This specialized peptide is designed to interfere with the FOXO4-p53 interaction, a pathway that has become a major focus in longevity and healthy aging studies. Research suggests that disruption of this interaction may selectively affect senescent cells, making FOXO4-DRI a valuable tool for laboratory investigations into age-related cellular processes.

Manufactured as a lyophilized powder, FOXO4-DRI utilizes D-retro-inverso technology, which enhances peptide stability and resistance to enzymatic degradation while maintaining biological target recognition. This characteristic makes it suitable for demanding research applications involving cell biology, regenerative science, and senescence-related pathways.

Key Features

• 10mg FOXO4-DRI per vial
• High-purity research-grade peptide
• D-retro-inverso peptide design
• Studied in cellular senescence research
• Enhanced stability against enzymatic degradation
• Lyophilized powder for laboratory applications
• Intended exclusively for research use

Research Applications

• Cellular senescence studies
• Senolytic mechanism research
• Longevity and healthy aging investigations
• FOXO4-p53 interaction analysis
• Cell survival and apoptosis research
• Age-related biological pathway studies

Benefits for Research

• Supports advanced senescence-related studies
• Investigated for selective senescent cell targeting
• Useful for molecular biology and aging research
• Designed for enhanced peptide stability
• Widely referenced in longevity-focused scientific literature

Product Information

• Product Name: FOXO4-DRI
• Quantity: 10mg
• Form: Lyophilized Powder
• Purity: High Research Grade
• Storage: Store refrigerated according to laboratory standards
• Intended Use: Research Purposes Only